1.
Comparative population pharmacokinetics and absolute oral bioavailability of COX-2 selective inhibitors celecoxib, mavacoxib and meloxicam in cockatiels (Nymphicus hollandicus)
2.
Development of an in vivo lipopolysaccharide inflammation model to study the pharmacodynamics of COX-2 inhibitors celecoxib, mavacoxib, and meloxicam in cockatiels (Nymphicus holla...